RxDoctor Payments DataLook up a doctor →

Amanda Goke, APRN

Family · Columbia, TNNPI 1649800871

Payments from drug & device makers

$22,515in general payments, 2019–2025

Across 1,059 payments — averaging $21.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$2K
  • Livanova USA, Inc.$2K
  • AbbVie$2K
  • Biogen$1K
  • AstraZeneca$1K
  • ANI Pharmaceuticals, Inc.$1K
  • plus $13K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
UCB, Inc.66$1,951
Livanova USA, Inc.8$1,695
AbbVie97$1,528
Biogen65$1,398
AstraZeneca(2 entities)52$1,299
ANI Pharmaceuticals, Inc.53$1,139
Novartis55$1,110
Teva Pharmaceuticals USA, Inc.32$823
Neurocrine Biosciences, Inc.32$772
EMD Serono, Inc.46$759
Lilly USA, LLC46$728
SK Life Science, Inc.44$653
Pfizer52$633
Harmony Biosciences LLC24$585
Eisai Inc.39$492
Jazz Pharmaceuticals Inc.19$474
Neurelis, Inc.27$428
TG Therapeutics, Inc.19$395
Acadia Pharmaceuticals Inc17$323
Axsome Therapeutics, Inc.18$320
Biohaven Pharmaceutical Holding Company Ltd.13$284
Lundbeck LLC16$272
Bristol Myers Squibb16$250
Banner Life Sciences, LLC13$248
Catalyst Pharmaceuticals, Inc.11$232
Genentech USA, Inc.11$232
Grifols USA, LLC12$229
Kyowa Kirin, Inc.9$198
CSL Behring7$192
Argenx US, Inc.9$189
Inspire Medical Systems, Inc.6$168
Johnson & Johnson10$161
Boston Scientific3$158
Upsher-smith Laboratories LLC9$152
Impel Pharmaceuticals Inc.8$136
Avanir Pharmaceuticals, Inc.6$134
Octapharma USA, Inc.5$126
Otsuka America Pharmaceutical, Inc.7$124
Avadel CNS Pharmaceuticals, LLC4$117
Sumitomo Pharma America, Inc.6$112
Alnylam Pharmaceuticals Inc.6$111
Amgen6$102
Mallinckrodt Hospital Products Inc.4$102
Tanabe Pharma America, Inc.6$97
Avion Pharmaceuticals5$89
MDD US Operations, LLC4$87
Merz Pharmaceuticals, LLC3$67
Scilex Pharmaceuticals Inc.3$59
Ipsen Biopharmaceuticals, Inc3$56
Vanda Pharmaceuticals Inc.2$54
Azurity Pharmaceuticals, Inc.3$51
Sanofi2$50
Takeda Pharmaceuticals U.S.A., Inc.2$47
Aucta Pharmaceuticals, Inc.2$45
Impel Pharmaceuticals LLC2$43
Adamas Pharmaceuticals, Inc.2$38
Currax Pharmaceuticals LLC2$35
Amneal Pharmaceuticals LLC2$34
Almatica Pharma LLC2$31
Revance Therapeutics, Inc.1$27

How this compares

$22,515 in reported general payments places this provider in the 95th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee →

Medicare billing

Part B allowed, 2024
$89,348
Medicare patients
424
Services billed
1,244

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Columbia

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →